ProCE Banner Activity

Current Limitations in PBC Pruritus Management

Clinical Thought

Explore my insights on limitations in PBC pruritus management and appreciate why patients desperately need more effective, better-tolerated treatment options.

Released: August 20, 2024

Expiration: August 19, 2025

Share

Faculty

Stuart C Gordon

Stuart C Gordon, MD, FACP, FACG, AGAF, FAASLD

Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This educational activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Disclosure

Primary Author

Stuart C Gordon, MD, FACP, FACG, AGAF, FAASLD

Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Stuart C. Gordon, MD, FACP, FACG, AGAF, FAASLD: researcher: AbbVie, Arbutus, COUR Pharmaceuticals, CymaBay, GlaxoSmithKline, Ipsen, Mirum Pharmaceuticals; advisor: CymaBay, GlaxoSmithKline, Ipsen.